SkinHealth Systems Inc. SKIN
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.42% | -6.46% | -8.17% | -10.02% | -13.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.42% | -6.46% | -8.17% | -10.02% | -13.15% |
| Cost of Revenue | -3.71% | -12.37% | -21.26% | -27.48% | -42.88% |
| Gross Profit | -4.77% | -3.14% | 0.90% | 3.19% | 15.96% |
| SG&A Expenses | -17.12% | -16.83% | -18.17% | -13.22% | -11.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.54% | -14.79% | -18.71% | -18.39% | -24.51% |
| Operating Income | 134.35% | 87.83% | 80.69% | 65.20% | 74.52% |
| Income Before Tax | -2.67% | -27.94% | 90.52% | 79.91% | 51.76% |
| Income Tax Expenses | 562.38% | 925.27% | 127.93% | 892.26% | -171.67% |
| Earnings from Continuing Operations | -55.73% | -49.61% | 84.28% | 67.29% | 58.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.73% | -49.61% | 84.28% | 67.29% | 58.31% |
| EBIT | 134.35% | 87.83% | 80.69% | 65.20% | 74.52% |
| EBITDA | 337.25% | 360.30% | 159.04% | 117.42% | 115.36% |
| EPS Basic | -51.49% | -44.02% | 85.13% | 68.05% | 57.96% |
| Normalized Basic EPS | -186.76% | -124.22% | 90.83% | 89.46% | 91.97% |
| EPS Diluted | 34.23% | 20.66% | 57.87% | 53.12% | 47.81% |
| Normalized Diluted EPS | -103.43% | -89.36% | 86.63% | 84.73% | 87.87% |
| Average Basic Shares Outstanding | 2.50% | 2.43% | 2.20% | 2.06% | 0.57% |
| Average Diluted Shares Outstanding | 0.38% | 0.29% | 2.05% | -2.83% | -4.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |